The present invention is directed to disubstituted azepan and oxazepan amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin re
-
Page/Page column 40
(2010/05/13)
More Articles about upstream products of 1224374-16-6